P1‐129: CELL‐AUTONOMOUS AND EFFECTS OF NEURONAL BIN1 LOSS IN VIVO Article Swipe
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1016/j.jalz.2019.06.684
BIN1 has been identified as the most important risk locus for Late Onset Alzheimer's Disease (LOAD), after ApoE. BIN1-associated SNPs correlate with tau deposition as well as with hippocampal atrophy. Furthermore, while the total amount of BIN1 mRNA increases, the level of neuronal-specific BIN1 isoform 1 protein is decreased in sporadic AD cases and this decrease parallels to neuronal loss. In this study, we knocked-down endogenous Bin1 either in the hippocampus or conditionally in neurons of mice expressing tau P301S (PS19) to understand whether the loss of BIN1 in conjunction to tau deposition is causative of neuronal loss. We delivered Bin1-shRNA into the hippocampus of PS19 mice via stereotaxic injection of Adeno-associated Virus (AAV)-Bin1 shRNA. To investigate whether the neuronal loss is due to deletion of Bin1 in neurons in presence or in absence of tau P301S, we bred Bin1fl/fl mice with mice expressing Cre under the neuronal promoter of Thy1, and subsequently with PS19. We observed a statistically significant reduction in the number of neurons in the hippocampus of mice injected with AAV-Bin1 shRNA in comparison with mice injected with AAV control. We observed that mice lacking Bin1 exclusively in neurons and expressing tau P301S die earlier, but they don't show any difference in the number of neurons. The loss of neuronal Bin1 resulted in an increased susceptibility to pharmacologically-induced seizure, and an increased activation of c-fos in vivo. Taken together, our data suggest that the effect of BIN1 on Alzheimer's Disease risk could be partially due to a cell autonomous role of neuronal Bin1, eventually exacerbated by the presence of mutant tau. Further studies are currently ongoing to understand the mechanisms underlying these effects.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.jalz.2019.06.684
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.684
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2981067732
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2981067732Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.jalz.2019.06.684Digital Object Identifier
- Title
-
P1‐129: CELL‐AUTONOMOUS AND EFFECTS OF NEURONAL BIN1 LOSS IN VIVOWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-07-01Full publication date if available
- Authors
-
Hameetha Banu Rajamohamed Sait, Kathleen M. McAvoy, Galina Marsh, Michael Peterson, Taylor L. Reynolds, Jake Gagnon, Sarah Geisler, Chris Roberts, Richard M. Ransohoff, Andrea CrottiList of authors in order
- Landing page
-
https://doi.org/10.1016/j.jalz.2019.06.684Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.684Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.684Direct OA link when available
- Concepts
-
Hippocampal formation, In vivo, Hippocampus, Biology, Neurodegeneration, Small hairpin RNA, Neuroscience, Molecular biology, Endocrinology, Internal medicine, Gene knockdown, Medicine, Cell culture, Genetics, DiseaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2981067732 |
|---|---|
| doi | https://doi.org/10.1016/j.jalz.2019.06.684 |
| ids.doi | https://doi.org/10.1016/j.jalz.2019.06.684 |
| ids.mag | 2981067732 |
| ids.openalex | https://openalex.org/W2981067732 |
| fwci | 0.0 |
| type | article |
| title | P1‐129: CELL‐AUTONOMOUS AND EFFECTS OF NEURONAL BIN1 LOSS IN VIVO |
| biblio.issue | 7S_Part_5 |
| biblio.volume | 15 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10086 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.8353999853134155 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Alzheimer's disease research and treatments |
| topics[1].id | https://openalex.org/T10301 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.7825999855995178 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Mitochondrial Function and Pathology |
| is_xpac | False |
| apc_list.value | 4000 |
| apc_list.currency | USD |
| apc_list.value_usd | 4000 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C148762608 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7578425407409668 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q3748185 |
| concepts[0].display_name | Hippocampal formation |
| concepts[1].id | https://openalex.org/C207001950 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6865278482437134 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q141124 |
| concepts[1].display_name | In vivo |
| concepts[2].id | https://openalex.org/C2781161787 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6657820343971252 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q48360 |
| concepts[2].display_name | Hippocampus |
| concepts[3].id | https://openalex.org/C86803240 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5555737018585205 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[3].display_name | Biology |
| concepts[4].id | https://openalex.org/C2776925932 |
| concepts[4].level | 3 |
| concepts[4].score | 0.4168604016304016 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1755122 |
| concepts[4].display_name | Neurodegeneration |
| concepts[5].id | https://openalex.org/C190232843 |
| concepts[5].level | 4 |
| concepts[5].score | 0.41509103775024414 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1950808 |
| concepts[5].display_name | Small hairpin RNA |
| concepts[6].id | https://openalex.org/C169760540 |
| concepts[6].level | 1 |
| concepts[6].score | 0.371649831533432 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[6].display_name | Neuroscience |
| concepts[7].id | https://openalex.org/C153911025 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3579505681991577 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[7].display_name | Molecular biology |
| concepts[8].id | https://openalex.org/C134018914 |
| concepts[8].level | 1 |
| concepts[8].score | 0.349222332239151 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[8].display_name | Endocrinology |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.31707799434661865 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C173396325 |
| concepts[10].level | 3 |
| concepts[10].score | 0.2919553518295288 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1501275 |
| concepts[10].display_name | Gene knockdown |
| concepts[11].id | https://openalex.org/C71924100 |
| concepts[11].level | 0 |
| concepts[11].score | 0.21781158447265625 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[11].display_name | Medicine |
| concepts[12].id | https://openalex.org/C81885089 |
| concepts[12].level | 2 |
| concepts[12].score | 0.20531097054481506 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q189082 |
| concepts[12].display_name | Cell culture |
| concepts[13].id | https://openalex.org/C54355233 |
| concepts[13].level | 1 |
| concepts[13].score | 0.11172565817832947 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[13].display_name | Genetics |
| concepts[14].id | https://openalex.org/C2779134260 |
| concepts[14].level | 2 |
| concepts[14].score | 0.07862129807472229 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[14].display_name | Disease |
| keywords[0].id | https://openalex.org/keywords/hippocampal-formation |
| keywords[0].score | 0.7578425407409668 |
| keywords[0].display_name | Hippocampal formation |
| keywords[1].id | https://openalex.org/keywords/in-vivo |
| keywords[1].score | 0.6865278482437134 |
| keywords[1].display_name | In vivo |
| keywords[2].id | https://openalex.org/keywords/hippocampus |
| keywords[2].score | 0.6657820343971252 |
| keywords[2].display_name | Hippocampus |
| keywords[3].id | https://openalex.org/keywords/biology |
| keywords[3].score | 0.5555737018585205 |
| keywords[3].display_name | Biology |
| keywords[4].id | https://openalex.org/keywords/neurodegeneration |
| keywords[4].score | 0.4168604016304016 |
| keywords[4].display_name | Neurodegeneration |
| keywords[5].id | https://openalex.org/keywords/small-hairpin-rna |
| keywords[5].score | 0.41509103775024414 |
| keywords[5].display_name | Small hairpin RNA |
| keywords[6].id | https://openalex.org/keywords/neuroscience |
| keywords[6].score | 0.371649831533432 |
| keywords[6].display_name | Neuroscience |
| keywords[7].id | https://openalex.org/keywords/molecular-biology |
| keywords[7].score | 0.3579505681991577 |
| keywords[7].display_name | Molecular biology |
| keywords[8].id | https://openalex.org/keywords/endocrinology |
| keywords[8].score | 0.349222332239151 |
| keywords[8].display_name | Endocrinology |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.31707799434661865 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/gene-knockdown |
| keywords[10].score | 0.2919553518295288 |
| keywords[10].display_name | Gene knockdown |
| keywords[11].id | https://openalex.org/keywords/medicine |
| keywords[11].score | 0.21781158447265625 |
| keywords[11].display_name | Medicine |
| keywords[12].id | https://openalex.org/keywords/cell-culture |
| keywords[12].score | 0.20531097054481506 |
| keywords[12].display_name | Cell culture |
| keywords[13].id | https://openalex.org/keywords/genetics |
| keywords[13].score | 0.11172565817832947 |
| keywords[13].display_name | Genetics |
| keywords[14].id | https://openalex.org/keywords/disease |
| keywords[14].score | 0.07862129807472229 |
| keywords[14].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1016/j.jalz.2019.06.684 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S108427512 |
| locations[0].source.issn | 1552-5260, 1552-5279 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1552-5260 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Alzheimer s & Dementia |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.684 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Alzheimer's & Dementia |
| locations[0].landing_page_url | https://doi.org/10.1016/j.jalz.2019.06.684 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5041674731 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Hameetha Banu Rajamohamed Sait |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[0].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[0].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Biogen (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hameetha Banu Rajamohamed Sait |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[1].author.id | https://openalex.org/A5083522758 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Kathleen M. McAvoy |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[1].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[1].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[1].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Biogen (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kathleen Mcavoy |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[2].author.id | https://openalex.org/A5113853333 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Galina Marsh |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[2].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[2].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[2].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Biogen (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Galina Marsh |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[3].author.id | https://openalex.org/A5009538189 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0337-6049 |
| authorships[3].author.display_name | Michael Peterson |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[3].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[3].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Biogen (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Michael Peterson |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[4].author.id | https://openalex.org/A5025353987 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6941-0900 |
| authorships[4].author.display_name | Taylor L. Reynolds |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[4].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[4].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[4].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Biogen (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Taylor L. Reynolds |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[5].author.id | https://openalex.org/A5055641838 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Jake Gagnon |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[5].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[5].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Biogen (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jake Gagnon |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[6].author.id | https://openalex.org/A5110229350 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Sarah Geisler |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[6].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[6].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[6].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Biogen (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Sarah Geisler |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[7].author.id | https://openalex.org/A5067744839 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Chris Roberts |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[7].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[7].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[7].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Biogen (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Chris Roberts |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| authorships[8].author.id | https://openalex.org/A5106628261 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Richard M. Ransohoff |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210142066 |
| authorships[8].affiliations[0].raw_affiliation_string | Third Rock Ventures, Boston, MA, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210142066 |
| authorships[8].institutions[0].ror | https://ror.org/03g5fjs36 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210142066 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Third Dimension Technologies (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Richard Ransohoff |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Third Rock Ventures, Boston, MA, USA |
| authorships[9].author.id | https://openalex.org/A5017936081 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-9421-4370 |
| authorships[9].author.display_name | Andrea Crotti |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1297540436 |
| authorships[9].affiliations[0].raw_affiliation_string | Biogen, Cambridge, MA, USA |
| authorships[9].institutions[0].id | https://openalex.org/I1297540436 |
| authorships[9].institutions[0].ror | https://ror.org/02jqkb192 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I1297540436 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Biogen (United States) |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Andrea Crotti |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Biogen, Cambridge, MA, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.684 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2019-10-25T00:00:00 |
| display_name | P1‐129: CELL‐AUTONOMOUS AND EFFECTS OF NEURONAL BIN1 LOSS IN VIVO |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10086 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.8353999853134155 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Alzheimer's disease research and treatments |
| related_works | https://openalex.org/W2794217300, https://openalex.org/W2764192351, https://openalex.org/W2965213848, https://openalex.org/W2102136350, https://openalex.org/W3031633328, https://openalex.org/W2090370544, https://openalex.org/W2391750868, https://openalex.org/W17166845, https://openalex.org/W2061706623, https://openalex.org/W4385683675 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.jalz.2019.06.684 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S108427512 |
| best_oa_location.source.issn | 1552-5260, 1552-5279 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1552-5260 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Alzheimer s & Dementia |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.684 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Alzheimer's & Dementia |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.jalz.2019.06.684 |
| primary_location.id | doi:10.1016/j.jalz.2019.06.684 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S108427512 |
| primary_location.source.issn | 1552-5260, 1552-5279 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1552-5260 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Alzheimer s & Dementia |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.684 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Alzheimer's & Dementia |
| primary_location.landing_page_url | https://doi.org/10.1016/j.jalz.2019.06.684 |
| publication_date | 2019-07-01 |
| publication_year | 2019 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 45 |
| abstract_inverted_index.a | 157, 249 |
| abstract_inverted_index.AD | 51 |
| abstract_inverted_index.In | 60 |
| abstract_inverted_index.To | 115 |
| abstract_inverted_index.We | 98, 155, 183 |
| abstract_inverted_index.an | 216, 223 |
| abstract_inverted_index.as | 4, 24, 26 |
| abstract_inverted_index.be | 245 |
| abstract_inverted_index.by | 258 |
| abstract_inverted_index.in | 49, 68, 73, 88, 127, 129, 132, 161, 166, 175, 190, 204, 215, 228 |
| abstract_inverted_index.is | 47, 93, 121 |
| abstract_inverted_index.of | 35, 41, 75, 86, 95, 104, 110, 125, 134, 149, 164, 169, 207, 211, 226, 238, 253, 261 |
| abstract_inverted_index.on | 240 |
| abstract_inverted_index.or | 71, 131 |
| abstract_inverted_index.to | 57, 81, 90, 123, 219, 248, 269 |
| abstract_inverted_index.we | 63, 137 |
| abstract_inverted_index.AAV | 181 |
| abstract_inverted_index.Cre | 144 |
| abstract_inverted_index.The | 209 |
| abstract_inverted_index.and | 53, 151, 192, 222 |
| abstract_inverted_index.any | 202 |
| abstract_inverted_index.are | 266 |
| abstract_inverted_index.but | 198 |
| abstract_inverted_index.die | 196 |
| abstract_inverted_index.due | 122, 247 |
| abstract_inverted_index.for | 10 |
| abstract_inverted_index.has | 1 |
| abstract_inverted_index.our | 232 |
| abstract_inverted_index.tau | 22, 78, 91, 135, 194 |
| abstract_inverted_index.the | 5, 32, 39, 69, 84, 102, 118, 146, 162, 167, 205, 236, 259, 271 |
| abstract_inverted_index.via | 107 |
| abstract_inverted_index.BIN1 | 0, 36, 43, 87, 239 |
| abstract_inverted_index.Bin1 | 66, 126, 188, 213 |
| abstract_inverted_index.Late | 11 |
| abstract_inverted_index.PS19 | 105 |
| abstract_inverted_index.SNPs | 19 |
| abstract_inverted_index.been | 2 |
| abstract_inverted_index.bred | 138 |
| abstract_inverted_index.cell | 250 |
| abstract_inverted_index.data | 233 |
| abstract_inverted_index.into | 101 |
| abstract_inverted_index.loss | 85, 120, 210 |
| abstract_inverted_index.mRNA | 37 |
| abstract_inverted_index.mice | 76, 106, 140, 142, 170, 178, 186 |
| abstract_inverted_index.most | 6 |
| abstract_inverted_index.risk | 8, 243 |
| abstract_inverted_index.role | 252 |
| abstract_inverted_index.show | 201 |
| abstract_inverted_index.tau. | 263 |
| abstract_inverted_index.that | 185, 235 |
| abstract_inverted_index.they | 199 |
| abstract_inverted_index.this | 54, 61 |
| abstract_inverted_index.well | 25 |
| abstract_inverted_index.with | 21, 27, 141, 153, 172, 177, 180 |
| abstract_inverted_index.ApoE. | 17 |
| abstract_inverted_index.Bin1, | 255 |
| abstract_inverted_index.Onset | 12 |
| abstract_inverted_index.P301S | 79, 195 |
| abstract_inverted_index.PS19. | 154 |
| abstract_inverted_index.Taken | 230 |
| abstract_inverted_index.Thy1, | 150 |
| abstract_inverted_index.Virus | 112 |
| abstract_inverted_index.after | 16 |
| abstract_inverted_index.c-fos | 227 |
| abstract_inverted_index.cases | 52 |
| abstract_inverted_index.could | 244 |
| abstract_inverted_index.don't | 200 |
| abstract_inverted_index.level | 40 |
| abstract_inverted_index.locus | 9 |
| abstract_inverted_index.loss. | 59, 97 |
| abstract_inverted_index.shRNA | 174 |
| abstract_inverted_index.these | 274 |
| abstract_inverted_index.total | 33 |
| abstract_inverted_index.under | 145 |
| abstract_inverted_index.vivo. | 229 |
| abstract_inverted_index.while | 31 |
| abstract_inverted_index.(PS19) | 80 |
| abstract_inverted_index.P301S, | 136 |
| abstract_inverted_index.amount | 34 |
| abstract_inverted_index.effect | 237 |
| abstract_inverted_index.either | 67 |
| abstract_inverted_index.mutant | 262 |
| abstract_inverted_index.number | 163, 206 |
| abstract_inverted_index.shRNA. | 114 |
| abstract_inverted_index.study, | 62 |
| abstract_inverted_index.(LOAD), | 15 |
| abstract_inverted_index.Disease | 14, 242 |
| abstract_inverted_index.Further | 264 |
| abstract_inverted_index.absence | 133 |
| abstract_inverted_index.isoform | 44 |
| abstract_inverted_index.lacking | 187 |
| abstract_inverted_index.neurons | 74, 128, 165, 191 |
| abstract_inverted_index.ongoing | 268 |
| abstract_inverted_index.protein | 46 |
| abstract_inverted_index.studies | 265 |
| abstract_inverted_index.suggest | 234 |
| abstract_inverted_index.whether | 83, 117 |
| abstract_inverted_index.AAV-Bin1 | 173 |
| abstract_inverted_index.atrophy. | 29 |
| abstract_inverted_index.control. | 182 |
| abstract_inverted_index.decrease | 55 |
| abstract_inverted_index.deletion | 124 |
| abstract_inverted_index.earlier, | 197 |
| abstract_inverted_index.effects. | 275 |
| abstract_inverted_index.injected | 171, 179 |
| abstract_inverted_index.neuronal | 58, 96, 119, 147, 212, 254 |
| abstract_inverted_index.neurons. | 208 |
| abstract_inverted_index.observed | 156, 184 |
| abstract_inverted_index.presence | 130, 260 |
| abstract_inverted_index.promoter | 148 |
| abstract_inverted_index.resulted | 214 |
| abstract_inverted_index.seizure, | 221 |
| abstract_inverted_index.sporadic | 50 |
| abstract_inverted_index.Bin1fl/fl | 139 |
| abstract_inverted_index.causative | 94 |
| abstract_inverted_index.correlate | 20 |
| abstract_inverted_index.currently | 267 |
| abstract_inverted_index.decreased | 48 |
| abstract_inverted_index.delivered | 99 |
| abstract_inverted_index.important | 7 |
| abstract_inverted_index.increased | 217, 224 |
| abstract_inverted_index.injection | 109 |
| abstract_inverted_index.parallels | 56 |
| abstract_inverted_index.partially | 246 |
| abstract_inverted_index.reduction | 160 |
| abstract_inverted_index.together, | 231 |
| abstract_inverted_index.(AAV)-Bin1 | 113 |
| abstract_inverted_index.Bin1-shRNA | 100 |
| abstract_inverted_index.activation | 225 |
| abstract_inverted_index.autonomous | 251 |
| abstract_inverted_index.comparison | 176 |
| abstract_inverted_index.deposition | 23, 92 |
| abstract_inverted_index.difference | 203 |
| abstract_inverted_index.endogenous | 65 |
| abstract_inverted_index.eventually | 256 |
| abstract_inverted_index.expressing | 77, 143, 193 |
| abstract_inverted_index.identified | 3 |
| abstract_inverted_index.increases, | 38 |
| abstract_inverted_index.mechanisms | 272 |
| abstract_inverted_index.underlying | 273 |
| abstract_inverted_index.understand | 82, 270 |
| abstract_inverted_index.Alzheimer's | 13, 241 |
| abstract_inverted_index.conjunction | 89 |
| abstract_inverted_index.exacerbated | 257 |
| abstract_inverted_index.exclusively | 189 |
| abstract_inverted_index.hippocampal | 28 |
| abstract_inverted_index.hippocampus | 70, 103, 168 |
| abstract_inverted_index.investigate | 116 |
| abstract_inverted_index.significant | 159 |
| abstract_inverted_index.stereotaxic | 108 |
| abstract_inverted_index.Furthermore, | 30 |
| abstract_inverted_index.knocked-down | 64 |
| abstract_inverted_index.subsequently | 152 |
| abstract_inverted_index.conditionally | 72 |
| abstract_inverted_index.statistically | 158 |
| abstract_inverted_index.susceptibility | 218 |
| abstract_inverted_index.BIN1-associated | 18 |
| abstract_inverted_index.Adeno-associated | 111 |
| abstract_inverted_index.neuronal-specific | 42 |
| abstract_inverted_index.pharmacologically-induced | 220 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5041674731 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I1297540436 |
| citation_normalized_percentile.value | 0.17509992 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |